Vol 54, No 6 (2020)
Letter to the Editors
Published online: 2020-10-05
Botulinum toxin in the treatment of intestinal pseudo-obstruction following a stroke
1, 2
, 3, 4
, 3, 4
Abstract
Not available
Keywords: botulinum toxinconstipationexternal anal sphincterspasticity
References
- Fonfria E, Maignel J, Lezmi S, et al. The Expanding Therapeutic Utility of Botulinum Neurotoxins. Toxins (Basel). 2018; 10(5).
- Brisinda G, Sivestrini N, Bianco G, et al. Treatment of gastrointestinal sphincters spasms with botulinum toxin A. Toxins (Basel). 2015; 7(6): 1882–1916.
- Madaliński MH, Sławek J, Duzyński W, et al. Side effects of botulinum toxin injection for benign anal disorders. European Journal of Gastroenterology & Hepatology. 2002;14. ; 853: 856.
- Madalinski MH, Slawek J, Zbytek B, et al. Topical nitrates and the higher doses of botulinum toxin for chronic anal fissure. Hepatogastroenterology. 2001; 48(40): 977–979.
- Ahmadi J, Azary S, Ashjaei B, et al. Intrasphincteric botulinum toxin injection in treatment of chronic idiopathic constipation in children. Iran J Pediatr. 2013; 23(5): 574–578.
- Wester T, Granström AL. Botulinum toxin is efficient to treat obstructive symptoms in children with Hirschsprung disease. Pediatr Surg Int. 2015; 31(3): 255–259.
- Wald A, Bharucha AE, Cosman BC, et al. ACG clinical guideline: management of benign anorectal disorders. Am J Gastroenterol. 2014; 109(8): 1141–57; (Quiz) 1058.
- Emile SH, Elfeki HA, Elbanna HG, et al. Efficacy and safety of botulinum toxin in treatment of anismus: A systematic review. World J Gastrointest Pharmacol Ther. 2016; 7(3): 453–462.
- Zhang Y, Wang ZN, He L, et al. Botulinum toxin type-A injection to treat patients with intractable anismus unresponsive to simple biofeedback training. World J Gastroenterol. 2014; 20(35): 12602–12607.
- Cuda T, Gunnarsson R, de Costa A. Symptoms and diagnostic criteria of acquired Megacolon - a systematic literature review. BMC Gastroenterol. 2018; 18(1): 25.
